Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Current Deferred Revenue (2024)

Historic Current Deferred Revenue for Camp4 Therapeutics (CAMP) over the last 1 years, with Q4 2024 value amounting to $385000.0.

  • Camp4 Therapeutics' Current Deferred Revenue changed N/A to $385000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $385000.0, marking a year-over-year change of. This contributed to the annual value of $385000.0 for FY2024, which is N/A changed from last year.
  • Camp4 Therapeutics' Current Deferred Revenue amounted to $385000.0 in Q4 2024.
  • Camp4 Therapeutics' Current Deferred Revenue's 5-year high stood at $1.0 million during Q3 2024, with a 5-year trough of $385000.0 in Q4 2024.